OBJECTIVE: Multipl sclerosis is characterized by the destruction myelin and lipid metabolism occuring in central nervous system. OBJECTIVES: The present study was planned to investigate the relationship between the plasma lipid profile and disease activity in patients with relapsing remitting multiple sclerosis (RRMS). METHODS: In 27 RRMS patients, cranial magnetic resonance imaging (MRI) was performed monthly, during the 6 months. Within the same day, blood samples were collected and neurological examinations were done. Number of the lesions with contrast enhancement were determined. Levels of the plasma cholesterol, triglceride, low density lipoprotein (LDL) and high density lipoprotein (HDL) were measuered. As a control group 18 pe...
Background: Lack of resolution of inflammation may be considered a critical player for the onset and...
Objective: To investigate the prospective associations between adiposity and lipid-related variables...
PURPOSE:Early diagnosis and treatment of multiple sclerosis-related progressive multifocal leukoence...
OBJECTIVES: The present study was planned to investigate the relationship between the plasma lipid ...
Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS leading to demyelination and ax...
Multiple sclerosis (MS) is a chronic central nervous system disease that is associated with progress...
Altered lipid metabolism is a feature of chronic infammatory disorders. Increased plasma lipids and ...
Multiple sclerosis (MS) is an inflammatory, autoimmune disorder of the central nervous system (CNS) ...
Objective: Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system. Lip...
OBJECTIVE: Our aim was to determine if the resonance intensity of choline-containing compounds (Cho)...
The pathophysiology of multiple sclerosis (MS) is complex with the presence of inflammation and neur...
Lipoproteins modulate innate and adaptive immune responses. In the chronic inflammatory disease mult...
Background: Multiple sclerosis (MS) is a chronic disabling disease of the central nervous system (CN...
Objective: To investigate the association between plasma levels of hemostasis inhibitors and MRI out...
OBJECTIVES: In multiple sclerosis (MS) oxidative injury likely plays a major role in disease progres...
Background: Lack of resolution of inflammation may be considered a critical player for the onset and...
Objective: To investigate the prospective associations between adiposity and lipid-related variables...
PURPOSE:Early diagnosis and treatment of multiple sclerosis-related progressive multifocal leukoence...
OBJECTIVES: The present study was planned to investigate the relationship between the plasma lipid ...
Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS leading to demyelination and ax...
Multiple sclerosis (MS) is a chronic central nervous system disease that is associated with progress...
Altered lipid metabolism is a feature of chronic infammatory disorders. Increased plasma lipids and ...
Multiple sclerosis (MS) is an inflammatory, autoimmune disorder of the central nervous system (CNS) ...
Objective: Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system. Lip...
OBJECTIVE: Our aim was to determine if the resonance intensity of choline-containing compounds (Cho)...
The pathophysiology of multiple sclerosis (MS) is complex with the presence of inflammation and neur...
Lipoproteins modulate innate and adaptive immune responses. In the chronic inflammatory disease mult...
Background: Multiple sclerosis (MS) is a chronic disabling disease of the central nervous system (CN...
Objective: To investigate the association between plasma levels of hemostasis inhibitors and MRI out...
OBJECTIVES: In multiple sclerosis (MS) oxidative injury likely plays a major role in disease progres...
Background: Lack of resolution of inflammation may be considered a critical player for the onset and...
Objective: To investigate the prospective associations between adiposity and lipid-related variables...
PURPOSE:Early diagnosis and treatment of multiple sclerosis-related progressive multifocal leukoence...